Adult-to-adult living-donor liver transplantation: The experience of the Université catholique de Louvain

Autor: Olga Ciccarelli, Jan Lerut, Pierre-François Laterre, Juan Manuel Rico Juri, Benoît Lengelé, Chantal De Reyck, Eliano Bonaccorsi-Riani, Milton Inostroza Nunez, Pierre Gianello, Laurent Coubeau, Samuele Iesari, Pierre Goffette
Přispěvatelé: UCL - SSS/IREC/CHEX - Pôle de chirgurgie expérimentale et transplantation, UCL - (SLuc) Service de chirurgie et transplantation abdominale, UCL - SSS/IREC/MEDA - Pôle de médecine aiguë, UCL - (SLuc) Service de soins intensifs, UCL - SSS/IONS/NEUR - Clinical Neuroscience, UCL - (SLuc) Service de radiologie, UCL - SSS/IREC/MORF - Pôle de Morphologie, UCL - (SLuc) Service de chirurgie plastique, University of l'Aquila, Italy - Department of biotechnological and applied clinical sciences, Las Higueras Hospital, Talcahuano, Chile - Hepatobiliopancreatic Unit, Centro medico Imbanaco, Cali, Colombia - Cirugia de Trasplantes, UCL - (SLuc) Autre
Jazyk: angličtina
Rok vydání: 2019
Předmět:
Adult
Graft Rejection
Male
Living-donor
medicine.medical_specialty
Hepatoblastoma
medicine.medical_treatment
030230 surgery
Liver transplantation
Risk Assessment
Hemangioendothelioma
Cohort Studies
Hospitals
University

03 medical and health sciences
0302 clinical medicine
Belgium
Interquartile range
Secondary liver tumor
medicine
Living Donors
Hepatectomy
Humans
Retrospective Studies
Donor hepatectomy
Small-for-size graft
Hepatocellular cancer
Hepatology
business.industry
Graft Survival
Liver Neoplasms
Gastroenterology
Age Factors
Middle Aged
medicine.disease
Prognosis
Survival Analysis
Transplant Recipients
Surgery
Liver Transplantation
Small-for-size syndrome
Treatment Outcome
Portal hypertension
030211 gastroenterology & hepatology
Female
Living donor liver transplantation
business
Liver Failure
Zdroj: Hepatobiliary & Pancreatic Diseases International, Vol. 18, no. 2, p. 132-142 (2019)
Hepatobiliary & pancreatic diseases international : HBPD INT, Vol. 18, no.2, p. 132-142 (2019)
Popis: Liver transplantation is the treatment for end-stage liver diseases and well-selected malignancies. The allograft shortage may be alleviated with living donation. The initial UCLouvain experience of adult living-donor liver transplantation (LDLT) is presented. A retrospective analysis of 64 adult-to-adult LDLTs performed at our institution between 1998 and 2016 was conducted. The median age of 29 (45.3%) females and 35 (54.7%) males was 50.2 years (interquartile range, IQR 32.9-57.5). Twenty-two (34.4%) recipients had no portal hypertension. Three (4.7%) patients had a benign and 33 (51.6%) a malignant tumor [19 (29.7%) hepatocellular cancer, 11 (17.2%) secondary cancer and one (1.6%) each hemangioendothelioma, hepatoblastoma and embryonal liver sarcoma]. Median donor and recipient follow-ups were 93 months (IQR 41-159) and 39 months (22-91), respectively. Right and left hemi-livers were implanted in 39 (60.9%) and 25 (39.1%) cases, respectively. Median weights of right- and left-liver were 810 g (IQR 730-940) and 454 g (IQR 394-534), respectively. Graft-to-recipient weight ratios (GRWRs) were 1.17% (right, IQR 0.98%-1.4%) and 0.77% (left, 0.59%-0.95%). One- and five-year patient survivals were 85% and 71% (right) vs. 84% and 58% (left), respectively. One- and five-year graft survivals were 74% and 61% (right) vs. 76% and 53% (left), respectively. The patient and graft survival of right and left grafts and of very small (
Databáze: OpenAIRE